SCHEMBL7075844

SCHEMBL7075844

Cc1cccc(Nn2ccnc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.46
CYP11B2 P19099 1/20 0.46
GAA P10253 2/20 0.44
CD38 P28907 1/20 0.44
KMT2A Q03164 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
PKM P14618 1/20 0.43
CYP1A2 P05177 3/20 0.42
CYP3A4 P08684 3/20 0.42
CYP2C19 P33261 3/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
MAPT P10636 2/20 0.42
HTT P42858 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
IMPDH2 P12268 1/20 0.40
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2404117 0.78 CYP3A4 (0.45) CYP11B1CYP11B2KMT2ACYP1A2CYP3A4
SCHEMBL7870381 0.78 CYP1A2 (0.50) GAAKMT2ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL27641960 0.76 KIF11 (0.50) GAAKMT2AMAPTHTTNPSR1
SCHEMBL13164564 0.71 CYP1A2 (0.56) CYP11B1CYP11B2GAAKMT2ASMN1; SMN2
Piperazine SCHEMBL4470401 0.70 CYP26A1 (0.39) CYP11B1CYP11B2KMT2ACYP1A2CYP3A4
M-Xylene SCHEMBL29245042 0.69 NFKB1 (0.60) CYP11B1CYP11B2GAACD38KMT2A
SCHEMBL872242 0.67 IDO1 (0.64) CYP11B1CYP11B2KMT2ACYP3A4MAPT
SCHEMBL2574204 0.67 HTT (0.42) GAAKMT2ASMN1; SMN2PKMCYP1A2
SCHEMBL10569930 0.66 NPSR1 (0.70) GAAKMT2ASMN1; SMN2PKMCYP1A2
SCHEMBL5991144 0.66 NOS1 (0.44) CD38CYP26A1FLT1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1370539-A1 HIV INHIBITING N-AMINOIMIDAZOLE DERIVATIVES K.U. Leuven Research and Development (BE) 2003-12-17 EP disclosed
WO-2002068395-A1 HIV INHIBITING N-AMINOIMIDAZOLE DERIVATIVES K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2002-09-06 WO disclosed